JAYPIRCA
As listed in the register: JAYPIRCA 100 mg, comprimé pelliculé
100 mg · comprimé pelliculé
- Prescription only
- Active substance
- Pirtobrutinib
- Made by
- ELI LILLY NEDERLAND (PAY-BAS)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (JAYPIRCA). It describes the substance, not this exact product.
Pirtobrutinib is a small molecule, noncovalent inhibitor of BTK.
BTK is a signaling protein of the B-cell antigen receptor (BCR) and cytokine receptor pathways.
Pirtobrutinib is primarily metabolized by CYP3A4 and direct glucuronidation by UGT1A8 and UGT1A9, in vitro.
A high-fat meal decreased the C max of pirtobrutinib by 23% and delayed t max by 1 hour.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-03-06
Safety of the active substance
From the US prescribing label for the same active substance (JAYPIRCA). It describes the substance, not this exact product.
Most commonly due to infections (4.7%) including COVID-19 (3.1% of all patients).
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
Spain1 matching products
Netherlands1 matching products
Details
| Made by | ELI LILLY NEDERLAND (PAY-BAS) |
|---|---|
| Active substance | Pirtobrutinib |
| Strength | 100 mg |
| Form | comprimé pelliculé |
| Route | orale |
| Dispensing (as stated by the register) | médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services HEMATOLOGIE · prescription hospitalière · liste I · prescription réservée aux médecins compétents en maladie du sang |
| Marketed | Yes, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/23/1738 |
| Name in the register | JAYPIRCA 100 mg, comprimé pelliculé |
| Packs | plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC aluminium de 60 comprimé(s) |
| CIS | 67881720 |
| CIP13 | 3400930276457 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).